Cryptogenic cirrhosis: What are we missing?

Current Gastroenterology Reports

Volumn 12, Issue 1, 2010, Pages 40-48

  Caldwell, Stephen ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Alcohol related liver disease; Autoimmune hepatitis; Cryptogenic cirrhosis; NAFLD (non alcoholic fatty liver disease); NASH (non alcoholic steatohepatitis); Viral hepatitis

Indexed keywords

LIVER ENZYME;

ABNORMAL LABORATORY RESULT; ALCOHOL CONSUMPTION; AUTOIMMUNE HEPATITIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE CLASSIFICATION; FAMILIAL MEDITERRANEAN FEVER; FAMILY HISTORY; GENETIC ASSOCIATION; HEPATITIS NON B NON C; HISTOPATHOLOGY; HUMAN; INFLAMMATORY INFILTRATE; LABORATORY TEST; LIVER CANCER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOGENESIS; PORTAL HYPERTENSION; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; FATTY LIVER; HEPATITIS, AUTOIMMUNE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; TERMINOLOGY AS TOPIC;

EID: 77950859491     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-009-0082-7     Document Type: Review

References (77)

1. JM Clark AM Diehl 2003 Nonalcoholic fatty liver disease: an under-recognized cause of cryptogenic cirrhosis JAMA 289 3000 3004 10.1001/jama.289.22.3000 12799409 (Pubitemid 37430103)
2. SH Caldwell DM Crespo 2004 The spectrum expanded: cryptogenic cirrhosis and the natural history of nonalcoholic fatty liver disease J Hepatol 40 578 584 10.1016/j.jhep.2004.02.013 15030972 (Pubitemid 38367778)
3. EE Powell WG Cooksley R Hanson, et al. 1990 The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 74 80 10.1002/hep.1840110114 2295475 This landmark paper from Powell et al. established that NASH can progress to a state of cirrhosis that lacks sufficient histologic change to define it as steatohepatitis (i.e., cryptogenic cirrhosis). Once established, this link led to our subsequent epidemiologic study (next reference) and that of Poonawala et al. [5], which strengthened the epidemiologic associations. Powell et al. also noted one of the earliest associations of this condition with hepatocellular cancer.
4. SH Caldwell DH Oelsner JC Iezzoni, et al. 1999 Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 664 669 10.1002/hep.510290347 10051466 1:STN:280:DyaK1M7mt1emtw%3D%3D
5. A Poonawala SP Nair PJ Thuluvath 2000 Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study Hepatology 32 689 692 10.1053/jhep.2000.17894 11003611 1:STN:280:DC%2BD3cvpsFKnsQ%3D%3D
6. E Bugianesi N Leone E Vanni, et al. 2002 Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular cancer Gastroenterology 123 134 140 10.1053/gast.2002.34168 12105842 (Pubitemid 34747534)
7. A Maheshwari PJ Thuluvath 2006 Cryptogenic cirrhosis and NAFLD: are they related? Am J Gastroenterol 101 664 668 10.1111/j.1572-0241.2006.00478.x 16464222 This compilation clearly demonstrated consistency between different studies confirming the relationship among obesity, diabetes, and cryptogenic cirrhosis now thought to often represent late-stage NASH. (Pubitemid 43340946)
8. A Duseja M Nanda A Das, et al. 2004 Prevalence of obesity, diabetes mellitus and hyperlipidemia in patients with cryptogenic liver cirrhosis Trop Gastroenterol 25 15 17 15303464
9. H Kojima S Sakuri M Matsumura, et al. 2006 Cryptogenic cirrhosis in the region where obesity is not prevalent World J Gastroenterol 12 2080 2085 16610061
10. H Sakugawa H Nakasone T Nakayoshi, et al. 2003 Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan Hepatogastroenterology 50 2005 2008 14696453
11. SH Caldwell DM Harris EE Hespenheide 2002 Is NASH under diagnosed among African Americans? Am J Gastroenterol 97 1496 1500 10.1111/j.1572-0241.2002. 05795.x 12094872
12. JD Browning KS Kumar MH Saboorian DL Thiele 2004 Ethnic differences in the prevalence of cryptogenic cirrhosis Am J Gastroenterol 99 292 298 10.1111/j.1572-0241.2004.04059.x 15046220 (Pubitemid 38279872)
13. S Heringlake A Schütte P Flemming, et al. 2009 Presumed cryptogenic liver disease in Germany: high prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology Z Gastroenterol 47 417 423 10.1055/s-0028-1109146 19418409 1:STN:280: DC%2BD1Mvis1CgtA%3D%3D
14. A Rubio-Tapia JA Murray 2007 The liver in celiac disease Hepatology 46 1650 1658 10.1002/hep.21949 17969053 1:CAS:528:DC%2BD2sXhtlOhsr%2FL (Pubitemid 350155546)
15. LA Adams S Sanderson KD Lindor P Angulo 2005 The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies J Hepatol 42 132 138 10.1016/j.jhep.2004.09.012 15629518 (Pubitemid 40038911)
16. M Abdelmalek J Ludwig KD Lindor 1995 Two cases from the spectrum of nonalcoholic steatohepatitis J Clin Gastroenterol 20 127 130 10.1097/00004836-199503000-00011 7769192 1:STN:280:DyaK2M3os12gsQ%3D%3D
17. MJ Contos W Cales RK Sterling, et al. 2001 Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis Liver Transpl 7 363 373 10.1053/jlts.2001.23011 11303298 1:STN:280:DC%2BD3MzisFSmtA%3D%3D (Pubitemid 32331542)
18. Caldwell SH, Al-Osaimi AMS, Argo CK: Nonalcoholic fatty liver disease. In Schiff's Diseases of the Liver, edn 10. Edited by Schiff ER, Sorrell MF, Maddrey WC. Philadelphia: Lippincott Williams and Wilkins; 2007:1122.
19. RG Lee 1989 Nonalcoholic steatohepatitis: a study of 49 patients Hum Pathol 20 594 598 10.1016/0046-8177(89)90249-9 2656500 1:STN:280: DyaL1M3ltlCmsg%3D%3D (Pubitemid 19164370)
20. VMD Struben EE Hespenheide SH Caldwell 2000 Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds Am J Med 108 9 13 10.1016/S0002- 9343(99)00315-0 11059435 1:STN:280:DC%2BD3crgslKjsQ%3D%3D (Pubitemid 30058272)
21. IR Willner B Waters SR Patil, et al. 2001 Ninety patients with nonalcoholic steatohepatitis: Insulin resistance, familial tendency, and severity of disease Am J Gastroenterol 96 2957 2961 10.1111/j.1572-0241.2001. 04667.x 11693332 1:STN:280:DC%2BD3MnjvVWqsQ%3D%3D
22. MF Abdelmalek C Liu J Shuster, et al. 2006 Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease Clin Gastroenterol Hepatol 4 1162 1169 10.1016/j.cgh.2006.06.001 16901766 1:CAS:528:DC%2BD28XhtVOrurjO (Pubitemid 44311647)
23. S Chitturi GC Farrell 2001 Etiopathogenesis of nonalcoholic steatohepatitis Semin Liv Dis 21 27 41 10.1055/s-2001-12927 1:CAS:528: DC%2BD3MXivFGns7Y%3D
24. DH Crawford RW Shepherd JW Halliday, et al. 1994 Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartments Gastroenterology 106 1611 1617 8194709 1:STN:280:DyaK2c3lt1Giuw%3D%3D
25. SJ Cotler K Kanji A Keshavarzian, et al. 2004 Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis J Clin Gastroenterol 38 801 804 10.1097/01.mcg.0000139072.38580.a0 15365409 (Pubitemid 39274184)
26. A Regev C Guaqueta EG Molina, et al. 2006 Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study J Pediatr Gastroenterol Nutr 43 S30 S35 10.1097/01.mpg.0000226387.56612.1e 16819398 1:CAS:528:DC%2BD28XmsVGjtLo%3D (Pubitemid 44014975)
27. J Koskinas JG Kenna GL Bird, et al. 1992 Immunoglobulin A antibody to a 200-kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitis Gastroenterology 103 1860 1867 1451979 1:CAS:528:DyaK3sXhvVGlsbs%3D
28. N Nagore PJ Scheuer 1988 Does a linear pattern of sinusoidal IgA deposition distinguish between alcoholic and diabetic liver disease? Liver 8 281 286 3059123 1:STN:280:DyaL1M%2FntVWlug%3D%3D
29. G Ayata FD Gordon WD Lewis, et al. 2002 Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation Human Pathol 33 1098 1104 10.1053/hupa.2002.129419 Along with Berg et al. [30] and the work of Duclos-Vallee et al., these authors proposed a working classification of cryptogenic cirrhosis based on clinicopathologic correlates and including cases attributable to NASH, silent autoimmune, unrecognized biliary disease, occult viral hepatitis, and occult ethanol exposure. This classification is continuing to evolve; a modified and extended form is included as Table 3 in the present paper. (Pubitemid 35416707)
30. T Berg R Neuhaus R Klein, et al. 2002 Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different outcomes after liver transplantation (OLT): a long-term documentation before and after OLT Transplantation 74 792 798 10.1097/00007890-200209270-00010 12364857 1:CAS:528:DC%2BD38XnsFOltrw%3D
31. S Caldwell V Lee D Kleiner, et al. 2009 NASH and cryptogenic cirrhosis: a histological analysis Ann Hepatol 8 346 352 20009134 This article, we believe, is the first of several focused studies to be published reporting on histologic footprints of NASH among series of patients with late-stage cryptogenic cirrhosis and prior histologically proven NASH. These studies have been consistent in showing histologic markers for prior steatohepatitis, including such findings as residual ballooning, glycogenated nuclei, and megamitochondria.
32. Clark ME, Ghotb A, Merriman RB: Longitudinal histologic evidence of loss of steatosis with progression of NAFLD to cirrhosis and liver transplantation. Gastroenterology (abstract) 2009, 136(suppl):T1017.
33. S Yatsuji E Hashimoto H Noto, et al. 2008 Clinicopathological features in nonalcoholic steatohepatitis autopsy cases Gastroenterology 134 Suppl 1 A783
34. SH Caldwell EE Hespenheide 2002 Subacute liver failure in obese females Am J Gastroenterol 97 2058 2062 10.1111/j.1572-0241.2002.05922.x 12190177
35. HP Cotrim R Parana E Braga L Lyra 2000 Nonalcoholic steatohepatitis and hepatocellular cancer: natural history? Am J Gastroenterol 95 3018 3019 10.1111/j.1572-0241.2000.03241.x 11051414 1:STN:280:DC%2BD3crgt12ksw%3D%3D
36. V Ratzui L Bonyhay V Di Martino, et al. 2002 Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis Hepatology 35 1485 1493 10.1053/jhep.2002.33324 (Pubitemid 34966903)
37. SH Caldwell DM Crespo HS Kang AM Al-Osaimi 2004 Obesity and hepatocellular carcinoma Gastroenterology 127 Suppl 1 S97 S103 10.1053/j.gastro.2004.09.021 15508109 1:CAS:528:DC%2BD2cXhtVGmtb%2FI (Pubitemid 39423375)
38. AJ Sanyal C Banas C Sargeant, et al. 2006 Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C Hepatology 43 682 689 10.1002/hep.21103 16502396
39. A Gastaldelli M Kozakova K Højlund RISC Investigators, et al. 2009 Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population Hepatology 49 1537 1544 10.1002/hep.22845 19291789 1:CAS:528:DC%2BD1MXlslKmurs%3D
40. S Nair S Verma PJ Thuluvath 2002 Obesity and the effect on survival in patients undergoing orthotopic liver transplantation in the United States Hepatology 35 105 109 10.1053/jhep.2002.30318 11786965 (Pubitemid 34032549)
41. J Ong ZM Younossi V Reddy, et al. 2001 Cryptogenic cirrhosis and post-transplantation non-alcoholic fatty liver disease Liver Transplant 7 797 801 10.1053/jlts.2001.24644 1:STN:280:DC%2BD3MrgtlWnsw%3D%3D (Pubitemid 32851301)
42. DS Sutedja PJ Gow SG Hubscher E Elias 2004 Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy Transplant Proc 36 2334 2337 10.1016/j.transproceed.2004.07.003 15561241 1:STN:280: DC%2BD2crovV2lsQ%3D%3D (Pubitemid 39550836)
43. MR Charlton M Kondo SK Roberts, et al. 1997 Liver transplantation for cryptogenic cirrhosis Liver Transpl Surg 3 359 364 10.1002/lt.500030402 9346764 1:STN:280:DyaK1c%2FgtlersQ%3D%3D
44. Duclos-Vallee JC, Yilmaz F, Johanet C, et al.: Could post-liver transplantation course be helpful for the diagnosis of so called cryptogenic cirrhosis? Clinical Transplant 2005, 19:591-599.
45. MA Heneghan T Zolfino P Muiesan, et al. 2003 An evaluation of long-term outcomes after transplantation for cryptogenic cirrhosis Liver Transpl 9 921 928 10.1053/jlts.2003.50165 12942453 (Pubitemid 37098840)
46. SK Roberts TM Therneau AJ Czaja 1996 Prognosis of histological cirrhosis in type 1 autoimmune hepatitis Gastroenterology 110 848 857 10.1053/gast.1996. v110.pm8608895 8608895 1:STN:280:DyaK287nslOguw%3D%3D (Pubitemid 26071852)
47. M Greeve L Ferrell M Kim, et al. 1993 Cirrhosis of undefined pathogenesis: absence of evidence for unknown or autoimmune processes Hepatology 17 593 598 10.1002/hep.1840170411 8386693 1:STN:280:DyaK3s3jvFWjug%3D%3D
48. VP Kodali SC Gordon AL Silverman DG McCray 1994 Cryptogenic liver disease in the united states: Further evidence for non-A, non-B, and non-C hepatitis Am J Gastroenterol 89 1836 1839 7942678 1:STN:280:DyaK2M%2FivFWqsg%3D%3D
49. MG Pessoa LD Terrault LD Ferrell, et al. 1997 Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation Hepatology 25 1266 1270 10.1002/hep.510250535 9141450 1:STN:280: DyaK2s3os1arsQ%3D%3D
50. I Castillo M Pardo J Bartolome, et al. 2004 Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown J Infect Dis 189 7 14 10.1086/380202 14702147 (Pubitemid 38122323)
51. C Brechot V Thiers D Kremsdorf, et al. 2001 Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 34 194 203 10.1053/jhep.2001.25172 11431751 1:STN:280:DC%2BD3MznsVKnuw%3D%3D (Pubitemid 32591500)
52. HT Chung CL Lai AS Lok 1995 Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis Hepatology 22 25 7601418 1:STN:280:DyaK2MzisVyrsg%3D%3D
53. PH Hayashi SA Harrison S Torgerson, et al. 2004 Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related Am J Gastroenterol 99 76 81 10.1046/j.1572-0241.2003.04013.x 14687145 (Pubitemid 38679105)
54. S Naveau V Giraud E Borotto, et al. 1997 Excess weight risk factor for alcoholic liver disease Hepatology 25 108 111 10.1002/hep.510250120 8985274 1:STN:280:DyaK2s7jvVanug%3D%3D
55. AM Diehl 2004 Obesity and alcoholic liver disease Alcohol 34 81 87 10.1016/j.alcohol.2004.07.010 15670669 1:CAS:528:DC%2BD2MXmvFOhsg%3D%3D (Pubitemid 40163991)
56. MJ Davies DJ Baer JT Judd, et al. 2003 Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women JAMA 287 2559 2562 10.1001/jama.287.19.2559
57. W Dunn R Xu JB Schwimmer 2008 Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease Hepatology 47 1947 1954 10.1002/hep.22292 18454505 (Pubitemid 351945562)
58. HP Cotrim LA Freitas E Alves, et al. 2009 Effects of light-to-moderate alcohol consumption on steatosis and steatohepatitis in severely obese patients Eur J Gastroenterol Hepatol 21 969 972 10.1097/MEG.0b013e328328f3ec 19194305 1:CAS:528:DC%2BD1MXps1Cjtbk%3D
59. HC Pinto A Baptista ME Camilo, et al. 1996 Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients Dig Dis Sci 41 172 179 10.1007/BF02208601 8565753 1:STN:280:DyaK287mtVOmtg%3D%3D (Pubitemid 26064854)
60. SO Sanderson TC Smyrk 2005 The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens Am J Clin Pathol 123 503 509 10.1309/1PX2LMPQUH1EE12U 15743753
61. V Ratziu E Bugianesi J Dixons, et al. 2007 Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability Aliment Pharmacol Ther 26 821 830 17767466 1:STN:280:DC%2BD2srntVKitg%3D%3D
62. R Nosadini A Avogaro F Mollo, et al. 1984 Carbohydrate and lipid metabolism in cirrhosis Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. J Clin Endocr Metab 58 1125 1132 1:STN:280:DyaL2c3ht12rtQ%3D%3D
63. O Matsui M Kadoya S Takahashi, et al. 1995 Focal sparing of segment IV in fatty livers shown by sonography and CT: correlation with aberrant gastric venous drainage Am J Roentgenol 164 1137 1140 1:STN:280:DyaK2M3jtlamsg%3D%3D
64. AM Seifalian C Piasecki A Agarwal BR Davidson 1999 The effect of graded steatosis on flow in the hepatic parenchymal microcirculation Transplantation 68 780 784 10.1097/00007890-199909270-00009 10515377 1:STN:280: DyaK1MvktlCjsg%3D%3D (Pubitemid 29468195)
65. T Roskams SQ Yang A Koteish, et al. 2003 Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease Am J Pathol 163 1301 1311 14507639 1:CAS:528:DC%2BD3sXotlegsbk%3D
66. MM Richardson JR Jonsson EE Powell, et al. 2007 Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction Gastroenterology 133 80 90 10.1053/j.gastro.2007.05.012 17631134 (Pubitemid 47031146)
67. C Lackner M Gogg-Kamerer K Zatloukal, et al. 2008 Ballooned hepatocytes in steatohepatitis: The value of keratin immunohistochemistry for diagnosis J Hepatol 48 821 828 10.1016/j.jhep.2008.01.026 18329127 1:CAS:528: DC%2BD1cXktVGruro%3D
68. R Carrozzo M Hirano B Fromenty, et al. 1998 Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses Neurology 50 99 106 9443465 1:CAS:528:DyaK1cXotVGitw%3D%3D
69. DR Johns 1995 Mitochondrial DNA and disease N Engl J Med 333 638 644 10.1056/NEJM199509073331007 7637726 1:CAS:528:DyaK2MXoslSgtbo%3D
70. N Tweezer-Zaks A Doron-Libner P Weiss, et al. 2007 Familial Mediterranean fever and cryptogenic cirrhosis Medicine 86 355 362 10.1097/MD.0b013e31815be056 18004180 (Pubitemid 351326058)
71. VR Chowdhary CS Crowson JJ Poterucha KG Moder 2008 Liver involvement in systemic lupus erythematosus: case review of 40 patients J Rheumatol 35 2159 2164 10.3899/jrheum.080336 18793002 1:CAS:528:DC%2BD1cXhsVKmtrjE
72. S Janello P Bosco M Camuto, et al. 2004 A mild form of Alstrom disease associated with metabolic syndrome and very high fasting free fatty acids: Two cases diagnosed in adult age Am J Med Sci 327 284 288 10.1097/00000441- 200405000-00031 (Pubitemid 38657616)
73. JL Badano N Mistuma PL Beales N Katsanis 2006 The ciliopathies: An emerging class of human genetic diseases Annu Rev Genomics Hum Genet 7 125 148 10.1146/annurev.genom.7.080505.115610 16722803 1:CAS:528:DC%2BD28Xht1WgsrzE (Pubitemid 44627925)
74. D Bonnefont-Rousselot B Condat A Sassolas, et al. 2009 Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B Eur J Gastroenterol Hepatol 21 104 108 10.1097/MEG.0b013e3282ffd9f8 19060634
75. JK Alder JJL Chen L Lancaster, et al. 2008 Short telomeres are a risk factor for idiopathic pulmonary fibrosis Proc Natl Acad Sci U S A 105 13051 13056 10.1073/pnas.0804280105 18753630
76. SM Ghobadloo B Yaghmaei V Bakayev, et al. 2004 GSTP1, GSTM1, and GSTT1 genetic polymorphisms in patients with cryptogenic liver cirrhosis J Gastrointest Surg 8 423 427 10.1016/j.gassur.2004.02.005 15120366 (Pubitemid 38561205)
77. N-M Ku R Gish TL Wright B Omary 2001 Keratin 8 mutations in patients with cryptogenic liver disease N Engl J Med 344 1580 1587 10.1056/ NEJM200105243442103 11372009 1:CAS:528:DC%2BD3MXkt1Oktrk%3D (Pubitemid 32479910)